Articles

Charles M.C. Lee, professor emeritus at the Stanford Graduate School of Business, has been questioning the wisdom of trading halts for some time.

Mizuho analysts are betting the stock of the small biotech Terns Pharmaceuticals Inc. could rally sharply if the company’s oral weight-loss drug proves successful when data from an early-stage trial is released later this year.

Surveys of consumers as well as businesses have been pessimistic for some time. Now the hard data, such as the retail-sales report for April, is starting to weaken as well, though it’s still much better than what the so-called soft data is suggesting.

Gold futures touch their highest levels in more than three weeks Wednesday after U.S. government data revealed a slowdown in the rate of inflation, feeding expectations for the return of interest-rate cuts this year.

Netflix will show live NFL games on Christmas Day in 2024, 2025 and 2026.

Wolfe Research analyst Steve Fleishman sees darker days ahead for SunPower shares after they’ve gotten caught up in the meme-stock momentum.

The vast majority of baby boomers who rent would rather not buy due to the high costs of homeownership, a Bank of America survey says.

“I have a very good nose, and it smells like the inside of an air freshener.”

Nir Bar Dea, chief executive officer at Bridgewater Associates, says his firm gets lots of market calls wrong, and investors need to acknowledge that they will be wrong a lot, too.

Cresco Labs Inc.’s stock rose Wednesday after the U.S. cannabis-dispensary operator matched analyst estimates for first-quarter revenue, as its loss narrowed.

Builder sentiment fell as mortgage rates stay elevated, the National Association of Home Builders said.

The average cost-of-living adjustment over the last 20 years has been about 2.6%, according to the Senior Citizens League